imatinib mesylate has been researched along with Colitis, Ulcerative in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 4 (50.00) | 2.80 |
Authors | Studies |
---|---|
Abdelaziz, RR; Ghoneim, HA; Shalaby, M; Suddek, GM | 1 |
Chapman, TP; Kennedy, J; Satsangi, J | 1 |
Peng, Y; Tan, D; Thomas, AS; Wang, Y; Wei, D | 1 |
Bassotti, G; Del Sordo, R; Lupinacci, G; Tanzi, G; Villanacci, V | 1 |
Flamourakis, M; Georgiou, G; Karmiris, K; Kazamias, G; Velegraki, M | 1 |
Alexander, RT; Anwar-Mohamed, A; Baksh, S; El-Kadi, AO; El-Kalla, M; Fernandez-Patron, C; Fiteih, Y; Ghazaleh, HA; Gordon, M; Law, J; Lee, SB; Liu, L; Mohamed, A; Odenbach, J; Onyskiw, C; Park, J; Thiesen, A; Volodko, N; Wine, E; Yu, VC; Zhao, Y | 1 |
Awano, N; Kitamura, S; Ryu, T; Takazoe, M; Tanaka, M; Yoshimura, N | 1 |
Al-Kindy, S; Al-Moundhri, MS; Al-Thahli, K; Rao, L; Salam, J | 1 |
8 other study(ies) available for imatinib mesylate and Colitis, Ulcerative
Article | Year |
---|---|
Imatinib mitigates experimentally-induced ulcerative colitis: Possible contribution of NF-kB/JAK2/STAT3/COX2 signaling pathway.
Topics: Acetic Acid; Animals; Colitis; Colitis, Ulcerative; Colon; Cyclooxygenase 2; Glutathione; Imatinib Mesylate; Janus Kinase 2; Male; NF-kappa B; Rats; Signal Transduction | 2023 |
Just Another Flare of Ulcerative Colitis?
Topics: Aged; Antineoplastic Agents; Biopsy; Colitis; Colitis, Ulcerative; Colonoscopy; Diagnosis, Differential; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestinal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Protein Kinase Inhibitors; Symptom Flare Up | 2020 |
An Aggressive Approach Toward a Case of Refractory Ulcerative Colitis With Uncertain Etiology in the Context of Chronic Myeloid Leukemia.
Topics: Aged; Colitis, Ulcerative; Colonoscopy; Dasatinib; Fatal Outcome; Fecal Microbiota Transplantation; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male | 2020 |
Imatinib and Dasatinib-induced Ulcerative Colitis: Case Report.
Topics: Colitis, Ulcerative; Dasatinib; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Pyrimidines | 2022 |
Replacement Resistant Iron Deficiency Anemia in a Patient With Ulcerative Colitis in Remission: Investigating Beyond the Obvious.
Topics: Anemia, Iron-Deficiency; Colitis, Ulcerative; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Iron; Iron Deficiencies; Middle Aged; Prognosis; Remission Induction | 2019 |
The tumor suppressor gene, RASSF1A, is essential for protection against inflammation -induced injury.
Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; bcl-2-Associated X Protein; Benzamides; Cell Cycle Proteins; Cell Proliferation; Colitis, Ulcerative; Colon; Dextran Sulfate; DNA-Binding Proteins; Epithelial Cells; Gene Expression Regulation; Imatinib Mesylate; Inflammation; Intestinal Mucosa; Mice; Mice, Knockout; NF-kappa B; Nuclear Proteins; Phosphoproteins; Piperazines; Proto-Oncogene Proteins c-abl; Pyrimidines; Signal Transduction; Toll-Like Receptors; Tumor Protein p73; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; YAP-Signaling Proteins | 2013 |
Successful treatment of ulcerative colitis associated with hypereosinophilic syndrome/chronic eosinophilic leukemia.
Topics: Benzamides; Chronic Disease; Colitis, Ulcerative; Female; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Piperazines; Pyrimidines; Treatment Outcome; Young Adult | 2011 |
Metastatic gastrointestinal stromal tumor and hypercalcemia in a patient with ulcerative colitis.
Topics: Antineoplastic Agents; Benzamides; Colitis, Ulcerative; Gastrointestinal Stromal Tumors; Humans; Hypercalcemia; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Rectum; Treatment Outcome | 2006 |